A
Ardelyx, Inc.
ARDX · NASDAQ · Healthcare · 1.0B
Closing price
$3.28
+0.31% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.7×
Enterprise value / EBITDAEV/EBITDA
-32.0×
Free cash flow yieldFCF yield
-5.6%
Return on equityROE
-36.9%
Operating margin
-10.1%
Net debt / EBITDAbalance-sheet strength
-4.9×
Interest coverage
-1.4×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.